Aldose Reductase Inhibitors: Structure–Activity Relationships and Therapeutic Potential
- 1 January 1989
- book chapter
- Published by Elsevier
- Vol. 18, 139-175
- https://doi.org/10.1016/b978-0-12-013318-5.50007-2
Abstract
No abstract availableThis publication has 127 references indexed in Scilit:
- Regulation of Insulin-Gene ExpressionNew England Journal of Medicine, 1987
- Effects of an aldose reductase inhibitor, 1-((p-bromophenyl)-sulfonyl)hydantoin, on cataract formation and tissue polyol levels in galactosemic rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Inhibition of aldose reductases from rabbit lens by oxazole derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Sorbitol, inositol and nerve conduction in diabetesLife Sciences, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983
- Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acidsJournal of Medicinal Chemistry, 1980
- Role of nonenzymatic glycosylation in experimental cataract formationBiochemical and Biophysical Research Communications, 1980
- Purification of alditol:NADP oxidoreductase from human placentaBiochemical and Biophysical Research Communications, 1972